Washington DC Veterans Affairs Medical Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Mary
S-CitAD, NCT03108846: Escitalopram for Agitation in Alzheimer's Disease

Active, not recruiting
3
187
Canada, US
Escitalopram, Lexapro, Placebo, non-applicable
JHSPH Center for Clinical Trials, National Institute on Aging (NIA)
Dementia
04/24
05/25
NCT02124174: Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Recruiting
2
50
US
Vidaza and Valproic Acid, Vidaza, Valproic Acid, Azacitadine
Patrick Stiff
Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS
01/22
01/22
LIFU_TUD, NCT06405074: Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula

Recruiting
N/A
44
US
low intensity focused ultrasound (LIFU)
Washington D.C. Veterans Affairs Medical Center
Tobacco Use Disorder
03/26
03/26
LIFU, NCT06453109: Focused Ultrasound for the Complex Patient

Recruiting
N/A
25
US
low intensity focused ultrasound (LIFU)
Washington D.C. Veterans Affairs Medical Center, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Chronic Back Pain, Anxiety
09/25
09/25
Rabiee, Atoosa
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
Kan, Virginia
INSIGHT12, NCT04910269 / 2021-001663-24: Outpatient Treatment With Anti-Coronavirus Immunoglobulin

Recruiting
3
820
Europe, US, RoW
Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
COVID, SARS-CoV2 Infection, Covid19
08/26
08/26
ICC, Washintgon
INSIGHT12, NCT04910269 / 2021-001663-24: Outpatient Treatment With Anti-Coronavirus Immunoglobulin

Recruiting
3
820
Europe, US, RoW
Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
COVID, SARS-CoV2 Infection, Covid19
08/26
08/26

Download Options